Altogether, these results demonstrated the key role of the Val145 site of LIF in binding with CVB‐D and then triggering mitophagy via the LIF/p38MAPK/p62 axis, accompanied by cell cycle arrest to combat HCC. The gene discussed is LIF; the disease is hepatocellular carcinoma.